Provision of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension

Medical Services Advisory Committee
Record ID 32002000066
Authors' objectives:

This report aims to assess the effectiveness of of pulmonary thromboendarterectomy (PTE) for chronic thromboembolic pulmonary hypertension.

Authors' results and conclusions: There have been no studies of rigorous methodology that have focused on the effectiveness of pulmonary thromboendarterectomy. None considered direct comparisons between PTE and either current best medical therapy or lung transplantation. Nevertheless, marked improvements are evident in survival, functional status (as measured using the New York Heart Association Functional Classification and scales measuring ability to perform activities of daily living), quality of life and haemodynamic outcomes.
Authors' recommendations: MSAC recommended that, on the strength of evidence pertaining to the efficacy and relative safety of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension, and the life threatening nature of this condition, public funding should be supported for this procedure to be performed in Australia.
Authors' methods: Systematic review
Project Status: Completed
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Endarterectomy
  • Pulmonary Embolism
Organisation Name: Medical Services Advisory Committee
Contact Address: MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
Contact Email:
Copyright: Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.